These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hairy cell leukemia: a model for studying the B cell family of diseases. Al-Katib A; Berman E; Black P; Koziner B Semin Oncol; 1986 Dec; 13(4 Suppl 5):48-54. PubMed ID: 3492047 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy. Vedantham S; Gamliel H; Golomb HM Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364 [TBL] [Abstract][Full Text] [Related]
7. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha. Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183 [TBL] [Abstract][Full Text] [Related]
8. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia. Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760 [TBL] [Abstract][Full Text] [Related]
9. Mid-term observations on the efficacy of alpha-interferon in hairy cell leukemia and status of the interferon system of patients in remission. Quesada JR; Lepe-Zuniga JL; Gutterman JU Leukemia; 1987 Apr; 1(4):317-9. PubMed ID: 3669753 [TBL] [Abstract][Full Text] [Related]
10. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia. Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762 [TBL] [Abstract][Full Text] [Related]
11. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia. Foa R; Fierro MT; Lusso P; Bonferroni M; Raspadori D; Buzzi M; Zinzani PL; Resegotti L; Lauria F Leukemia; 1987 Apr; 1(4):377-9. PubMed ID: 3499543 [TBL] [Abstract][Full Text] [Related]
13. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin]. Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434 [TBL] [Abstract][Full Text] [Related]
14. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity. Griffiths SD; Cawley JC Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763 [TBL] [Abstract][Full Text] [Related]
19. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175 [TBL] [Abstract][Full Text] [Related]